Fil LTD is of Cogent Biosciences, Inc.. Currently has a direct ownership of 1.14 Million shares of COGT, which is worth approximately $12.4 Million. The most recent transaction as insider was on Apr 03, 2018, when has been sold 1,138,274 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M
0% 3M change
0% 12M change
Total Value Held $12.4 Million

FIL Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2018
BUY
Conversion of derivative security
-
1,138,274 Added 50.0%
1,138,274 Common Stock

Also insider at

DNLI
Denali Therapeutics Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
SURF
Surface Oncology, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
BCAX
Bicara Therapeutics Inc.
FL

Fil LTD

Hamilton, D0

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Track Activities on COGT